Government & Public Health
Capability that stays after we leave
Trained people, deployed platforms, validated assay menus and local manufacturing - designed against technology-transfer and local-content obligations, not around them.
What we hear
What we hear from programme directors and ministries
- A national strategy with budget attached and a delivery gap underneath it
- Dependence on imported diagnostics and foreign analysis capacity
- Population genomics programmes generating data faster than it can be interpreted
- Procurement rules that reward local content, training and technology transfer
What we do about it
One workstream, one accountable lead
We build programmes rather than sell products. Every proposal quantifies what your own institutions will be able to do at the end: staff trained and certified, SOPs transferred, platforms deployed in-country, assays validated locally, and - where it applies - manufacturing established with a local partner.
Services
Most relevant capability
How we contract with public buyers
Milestone-based programmes with an explicit capability-transfer schedule. We work through local partners of record where tendering requires it, and we design for data residency and sovereignty from the first proposal rather than the security review.
Programme scale typically runs USD 300K–5M across multiple years.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.